Published by Nicolas Tierney
June 27, 2019
Regenerative medicine, broadly defined, is one of this century’s major medical trends. Its “value” is estimated conservatively in excess of $100 billion, with substantial growth forecast for many decades. Much of this value will inevitably accrue to product manufacturers and other non-practitioners. However, it should also accrue to those clinicians delivering evidence-based and regulatorily-compliant regenerative medicine procedures (“RMP’s”).
March 28, 2023
Statistical Significance and Clinical Relevance are two important concepts in the field of medicine, and particularly in clinical research. Being a bit more specific, statistical significance refers to the likelihood that a result is not due to chance.
March 17, 2023
Real-world evidence (RWE) is valuable not only for regulatory compliance, clinical decision-making and tracking adverse events. It can also drive patient engagement, profitability and professional advancement.
January 27, 2023
In this newsletter, we summarize the work of leading physicians as they develop clinical decision support for common musculoskeletal pathologies. Through the quality improvement and pragmatic studies embedded in their Circles, those clinicians are generating sustained financial and professional value for themselves, and improving patient care, with minimum burden. Moreover, their Circles are often supported by industry.